Heart Rate Variability as an Alternative Indicator for Identifying Cardiac Iron Status in Non-Transfusion Dependent Thalassemia Patients

被引:17
|
作者
Wijarnpreecha, Karn [1 ,2 ,3 ]
Siri-Angkul, Natthaphat [1 ,2 ,3 ]
Shinlapawittayatorn, Krekwit [1 ,2 ,3 ]
Charoenkwan, Pimlak [3 ,4 ]
Silvilairat, Suchaya [3 ,4 ]
Siwasomboon, Chate [5 ]
Visarutratna, Pannee [5 ]
Srichairatanakool, Somdet [6 ]
Tantiworawit, Adisak [7 ]
Phrommintikul, Arintaya [7 ]
Chattipakorn, Siriporn C. [1 ,3 ,8 ]
Chattipakorn, Nipon [1 ,2 ,3 ]
机构
[1] Chiang Mai Univ, Fac Med, Cardiac Electrophysiol Res & Training Ctr, Chiang Mai 50000, Thailand
[2] Chiang Mai Univ, Fac Med, Dept Physiol, Cardiac Electrophysiol Unit, Chiang Mai 50000, Thailand
[3] Chiang Mai Univ, Ctr Excellence Cardiac Elect, Chiang Mai 50000, Thailand
[4] Chiang Mai Univ, Fac Med, Dept Pediat, Chiang Mai 50000, Thailand
[5] Chiang Mai Univ, Fac Med, Dept Radiol, Chiang Mai 50000, Thailand
[6] Chiang Mai Univ, Fac Med, Dept Biochem, Chiang Mai 50000, Thailand
[7] Chiang Mai Univ, Fac Med, Dept Internal Med, Chiang Mai 50000, Thailand
[8] Chiang Mai Univ, Fac Med, Dept Oral Biol & Diagnost Sci, Chiang Mai 50000, Thailand
来源
PLOS ONE | 2015年 / 10卷 / 06期
关键词
TRANSFERRIN-BOUND IRON; LABILE PLASMA IRON; OXIDATIVE STRESS; OVERLOAD CARDIOMYOPATHY; MAGNETIC-RESONANCE; CHELATION-THERAPY; SERUM FERRITIN; RISK; PATHOPHYSIOLOGY; METABOLISM;
D O I
10.1371/journal.pone.0130837
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Iron-overload cardiomyopathy is a major cause of death in thalassemia patients due to the lack of an early detection strategy. Although cardiac magnetic resonance (CMR) T2* is used for early detection of cardiac iron accumulation, its availability is limited. Heart rate variability (HRV) has been used to evaluate cardiac autonomic function and found to be depressed in thalassemia. However, its direct correlation with cardiac iron accumulation has never been investigated. We investigated whether HRV can be used as an alternative indicator for early identification of cardiac iron deposition in thalassemia patients. Methods Ninety-nine non-transfusion dependent thalassemia patients (23.00 (17.00, 32.75) years, 35 male) were enrolled. The correlation between HRV recorded using 24-hour Holter monitoring and non-transferrin bound iron (NTBI), hemoglobin (Hb), serum ferritin, LV ejection fraction (LVEF), and CMR-T2* were determined. Results The median NTBI value was 3.15 (1.11, 6.59) mu M. Both time and frequency domains of HRV showed a significant correlation with the NTBI level, supporting HRV as a marker of iron overload. Moreover, the LF/HF ratio showed a significant correlation with CMR-T2* with the receiver operating characteristic (ROC) curve of 0.684 +/- 0.063, suggesting that it could represent the cardiac iron deposit in thalassemia patients. HRV was also significantly correlated with serum ferritin and Hb. Conclusions This novel finding regarding the correlation between HRV and CMR-T2* indicates that HRV could be a potential marker in identifying early cardiac iron deposition prior to the development of LV dysfunction, and may be used as an alternative to CMR-T2* for screening cardiac iron status in thalassemia patients.
引用
收藏
页数:14
相关论文
共 22 条
  • [1] Heart Rate Variability for Early Detection of Cardiac Iron Deposition in Patients with Transfusion-Dependent Thalassemia
    Silvilairat, Suchaya
    Charoenkwan, Pimlak
    Saekho, Suwit
    Tantiworawit, Adisak
    Phrommintikul, Arintaya
    Srichairatanakool, Somdet
    Chattipakorn, Nipon
    PLOS ONE, 2016, 11 (10):
  • [2] Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
    Bou-Fakhredin, Rayan
    Bazarbachi, Abdul-Hamid
    Chaya, Bachar
    Sleiman, Joseph
    Cappellini, Maria Domenica
    Taher, Ali T.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (12)
  • [3] Deferasirox: an orphan drug for chronic iron overload in non-transfusion dependent thalassemia syndromes
    Halawi, Racha
    Motta, Irene
    Taher, Ali
    Cappellini, Maria Domenica
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (06): : 677 - 686
  • [4] Diagnosis and treatment of cardiac iron overload in transfusion-dependent thalassemia patients
    Siri-Angkul, Natthaphat
    Chattipakorn, Siriporn C.
    Chattipakorn, Nipon
    EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (06) : 471 - 479
  • [5] Iron overload status in patients with non-transfusion-dependent thalassemia in China
    Huang, Yumei
    Yang, Gaohui
    Wang, Man
    Wei, Xiaoyun
    Pan, Lingyuan
    Liu, Jiaodi
    Lei, Yu
    Long, Liling
    Lai, Yongrong
    Liu, Rongrong
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [6] Treating iron overload in patients with non-transfusion-dependent thalassemia
    Taher, Ali T.
    Viprakasit, Vip
    Musallam, Khaled M.
    Cappellini, M. Domenica
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (05) : 409 - 415
  • [7] Heart Rate Variability for Early Detection of Iron Overload Cardiomyopathy in β-Thalassemia Patients
    Koonrungsesomboon, Nut
    Tantiworawit, Adisak
    Phrommintikul, Arintaya
    Saekho, Suwit
    Srichairattanakool, Somdet
    Chattipakorn, Nipon
    HEMOGLOBIN, 2015, 39 (04) : 281 - 286
  • [8] Correlation of NT-proBNP levels and cardiac iron concentration in patients with transfusion-dependent thalassemia major
    Delaporta, Polyxeni
    Kattamis, Antonios
    Apostolakou, Filia
    Boiu, Sorina
    Bartzeliotou, Anastasia
    Tsoukas, Evangelos
    Papassotiriou, Ioannis
    BLOOD CELLS MOLECULES AND DISEASES, 2013, 50 (01) : 20 - 24
  • [9] Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes
    Kontoghiorghe, Christina N.
    Kontoghiorghes, George J.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 465 - 481
  • [10] Correlation of Serum Ferritin and Cardiac Iron Toxicity with Cardiac Function in Transfusion Dependent Beta-Thalassemia Major Patients
    Atmakusuma, Tubagus Djumhana
    Kalwani, Rajesh
    Nasution, Sally Aman
    Rumende, Cleopas Martin
    ACTA MEDICA INDONESIANA, 2021, 53 (03) : 291 - 298